Melanin and its role on the virulence of Cryptococcus neoformans;Melani̇n ve cryptococcus neoformans' in vi̇rülansi üzeri̇ndeki̇ rolü

Mikrobiyoloji Bulteni

Volumn 44, Issue 3, 2010, Pages 519-526

  Alp, Şehnaz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cryptococcus neoformans; Melanin; Virulence factor

Indexed keywords

ANTIFUNGAL AGENT; MELANIN;

ANIMAL; ANTIFUNGAL RESISTANCE; BIOSYNTHESIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; REVIEW; VIRULENCE;

ANIMALS; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; HUMANS; MELANINS; PHAGOCYTOSIS; VIRULENCE;

EID: 77956391151     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 2006; 50: 3519-28. (Pubitemid 44684860)
2. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol 2003; 5: 203-23.
3. Enochs WS, Nilges MJ, Swartz HM. A standardized test for the identification and characterization of melanins using electron paramagnetic resonance (EPR) spectroscopy. Pigment Cell Res 1993; 6:91-9.
4. Wakamatsu K, Ito S. Advanced chemical methods in melanin determination. Pigment Cell Res 2002; 15: 174-83. (Pubitemid 34608975)
5. Staib F. Membrane filtration and Guizotia abyssinica culture media for the demonstration of Cryptococcus neoformans (brown color effect). Z Hyg Infektionskr 1963; 149: 329-36.
6. Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun 1995; 63: 3131-6.
7. Williamson PR, Wakamatsu K, Ito S. Melanin biosynthesis in Cryptococcus neoformans. J Bacteriol 1998; 180: 1570-2.
8. Kwon-Chung KJ, Tom WK, Costa JL. Utilization of indole compounds by Cryptococcus neoformans to produce a melanin-like pigment. J Clin Microbiol 1983; 18: 1419-21.
9. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996; 27: 839-47. (Pubitemid 26287228)
10. Wang Y, Casadevall A. Melanin, melanin 'ghosts', and melanin composition in Cryptococcus neoformans. Infect Immun 1996; 64: 2420-4.
11. Nosanchuk JD, Rosas AL, Casadevall A. The antibody response to fungal melanin in mice. J Immunol 1998; 160:6026-31. (Pubitemid 28298065)
12. Wang Y, Casadevall A. Decreased susceptibility of melanized Cryptococcus neoformans to UV light. Appl Environ Microbiol 1994; 60: 3864-6.
13. Rosas AL, Casadevall A. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol Lett 1997; 153: 265-72.
14. Garcia-Rivera J, Casadevall A. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate. Med Mycol 2001; 39: 353-7.
15. Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA 2001; 98: 15245-50.
16. Rosas AL, Casadevall A. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 2001; 151: 53-6.
17. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 1996; 184: 377-86.
18. Huffnagle GB, Chen GH, Curtis JL, McDonald RA Strieter RM, Toews GB. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 1995; 155: 3507-16.
19. Barluzzi R, Brozzetti A, Mariucci G, et al. Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain. J Neuroimmunol 2000; 109: 75-86.
20. Nosanchuk JD, Ovalle R, Casadevall A. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. J Infect Dis 2001; 183: 1093-9.
21. Rosas AL, Nosanchuk JD, Casadevall A. Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 2001; 69: 3410-2.
22. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 2000; 68: 2845-53.
23. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 1999; 19: 745-50.
24. Nosanchuk JD, Rosas AL, Lee SC, Casadevall A. Melianisation of Cryptococcus neoformans in human brain tissue. Lancet 2000; 355: 2049-50.
25. Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen-and oxygen-derived oxidants. Infect Immun 1994; 62: 3004-7.
26. Kozel TR. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated Cryptococcus neoformans. Infect Immun 1983; 39: 1214-9.
27. Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 1997; 65: 1836-41.
28. Doering TL, Nosanchuk JD, Roberts WK, Casadevall A. Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 1999; 37: 175-81. (Pubitemid 29326722)
29. Wang Y, Casadevall A. Growth of Cryptococcus neoformans in presence of L-dopa decreases Its susceptibility to amphotericin B. Antimicrob Agents Chemother 1994; 38: 2648-50.
30. Van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother 2002; 46: 3394-400.
31. Jacobson ES, Ikeda R. Effect of melanization upon porosity of the cryptococcal cell wall. Med Mycol 2005; 43: 327-33. (Pubitemid 41030459)
32. Rosas AL, Nosanchuk JD, Gómez BL, Edens WA, Henson JM, Casadevall A. Isolation and serological analyses of fungal melanins. J Immunol Methods 2000; 244: 69-80.
33. Rosas AL, MacGill RS, Nosanchuk JD, Kozel TR, Casadevall A. Activation of the alternative complement pathway by fungal melanins. Clin Diagn Laboratory Immunol 2002; 9: 144-8. (Pubitemid 34084290)
34. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000; 38: 407-17.
35. Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun 2000; 68: 832-8.
36. Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999; 67: 3703-13. (Pubitemid 29356981)